New concept of sJIA to MAS as a continuum on the spectrum of disease severity. Molecular basis via impact of mTORC1 (mechanistic target of rapamycin complex 1) inhibition in Il1rn-/- mice. Looking forward to the full paper. Huang Z Abs004 t.co/3OtIp90PnG #ACR22 @RheumNow
mTORC1 Drives the Spectrum of Pathology in Systemic JIA and Macrophage Activation Syndrome - ACR Meeting Abstracts


